#Sweden #Lund #Clinical Research #TFS HealthScience #global identity

TFS HealthScience Unveils New Global Brand Identity

Lund, Sweden - TFS HealthScience, a leading global clinical research organization (CRO), is making waves with the introduction of its new brand identity and slogan, "Securing the path from science to life." This transformative step, launched on October 5, 2026, is designed to reinforce the company's commitment to supporting biotech, pharmaceutical, and medical technology sponsors in over 40 countries.

Markus Granlund, the CEO of TFS HealthScience, expressed his excitement about the new brand, stating, "Our new brand clearly articulates who we are and where we’re heading. It represents our dedication to securing the path from scientific innovation to tangible health solutions, all achieved by a committed team that consistently goes above and beyond to make it happen."

The Essence of the New Brand

The rebranding initiative aims to emphasize TFS HealthScience’s focus on delivering clinical research services with a human touch. By centering their approach on fostering trust and transparency, the brand seeks to ensure that breakthroughs in medical science reach the patients who need them most.

This initiative is rooted deeply in their guiding philosophy of radical honesty. TFS aims to maintain clear communication with sponsors, ensuring they are informed of crucial data and insights early in the process. The focus on scientific urgency is also pivotal, as TFS is structured to enable swift decision-making, allowing for a more agile response to the needs of their clients.

Key Commitments

To reinforce this new identity, TFS HealthScience has outlined four key commitments that will guide their operational philosophy:
1. Radical Honesty: TFS teams communicate exactly what the data indicates and highlight significant findings upfront, ensuring sponsors are fully aware of study developments.
2. Scientific Urgency: The decision-making process is streamlined so that therapeutic leads hold direct authority to make prompt decisions, bypassing lengthy escalation procedures.
3. Therapeutic Depth: The organization specializes in five critical therapeutic areas: dermatology, internal medicine, neuroscience, oncology, and ophthalmology, with clinical leads who are well-versed in their respective fields before project kick-off.
4. Teams That Stay: TFS boasts an impressive statistic of 88% team retention throughout the duration of clinical trials. This rate is notably above the industry average, reflecting their commitment to maintaining continuity and consistency.

Sponsors can engage with TFS through various collaborative models, including full-service delivery, embedded resourcing, or a combination of both tailored to their specific needs and capacities.

A Vision for the Future

TFS HealthScience, since its establishment in Lund, Sweden, in 1996, has been dedicated to ushering scientific innovations into actionable medical solutions. With a commitment to transparency and efficiency, the newly unveiled brand is more than just a fresh logo or slogan; it's a clear declaration of the company’s vision moving forward.

The brand identity enhances TFS's position within the clinical research landscape, emphasizing their dedication to nurturing partnerships with biotech, pharma, and medtech industries as they navigate the complex path from laboratory research to patient care.

As part of this launch, TFS has also produced a brand film showcasing its team's dedication and the operational dynamics at play, emphasizing the seamless collaboration from initial patient enrollment to the database lock stage. This film can be viewed on their official website at tfscro.com/new-brand.

TFS HealthScience is committed to making strides in clinical research and ensuring that every study is an advancement toward improved health outcomes globally. Learn more about their mission and services at tfscro.com.